Neurotech International Ltd. has completed in vitro studies with human brain cells to evaluate and confirm the anti-inflammatory and neuromodulatory properties of its patented DOLCE/NTI cannabis strains, reports FinFeed. The completion of the plateau studies paves the way for the Australian company to proceed to a Phase 1 clinical trial.

The DOLCE/NTI varieties contain less than 0.3% THC, which is why they are classified as industrial hemp in Australia and the United States. In the UK, the THC limit for industrial hemp is 0.2% THC.

In vitro studies at Monash University, Wollongong University and RMIT University have shown that these strains significantly improve the health and viability of neuronal cells and have the ability to reduce inflammation compared to CBD alone, which can be used to treat autism, epilepsy, attention deficit hyperactivity disorder (ADHD), Alzheimer’s disease and other neurological disorders.

Brian Lidman, president of Neurotech, described the results of the study as very encouraging.

…especially the strong anti-inflammatory effects of our strains compared to CBD alone. These results suggest that DOLCE/NTI wires may have wider application in the treatment of a number of neurological disorders. – Lidman – FinFeed

Overall, the study found that the strains reduced the inflammation of brain cells by up to 60%, increased the overall health and viability of brain cells by up to 80% in the absence of toxic attacks, and increased the viability and productivity of mitochondria by up to 60%. According to Neurotech, each of these processes is an important process and outcome for understanding and maintaining brain function and cognitive health.

The Company expects to commence clinical trials in March 2021. Neurotech is listed on the Australian Securities Exchange under the symbol NTI.

View

Author:

TG Branfalt

TG joined the team in 2014 as news editor and began hosting the podcast in 2016. He lives in upstate New York, where he also teaches media studies at a local university.

phytocannabinoids benefits,cbd brain healing,cannabinoids increase brain cells,best cbd oil for neurological disorders,phytocannabinoids side effects,does cbd affect brain development,cbd rat study,Privacy settings,How Search works,phytocannabinoids effects

You May Also Like

Elon Musk Thinks CBD Is ‘Fake,’ But Joe Rogan Teaches Him A Lesson

Elon Musk may know a bit more about rockets and electronic machines, but in an interview with podcaster Joe Rogan this week, he revealed a blind spot regarding cannabis, saying he thinks CBD is “fake.” This does not mean that…

Reddit’s WallStreetBets Drives Market Volatility for Cannabis Stocks

Influenced by traders on /r/WallStreetBets, the Reddit-based forum that stirred the stock market last month with the launch of GameStop shares, shares of cannabis companies have seen volatile highs and lows this week, reports Business Insider. On Thursday, Tilray shares…

Connecticut Governor Unveils Adult-Use Legalization Proposal in Budget Request

After Steven Meland and Jeremy Breton, co-owners of Hotbox Farms, opened the doors to their 2019 clinic in Ontario, Oregon, lines formed, as they did at other clinics in the city. It was 5 a.m. when he heard someone knocking…

Virginia Advances Dueling Cannabis Legalization Bills

The Virginia House and Senate have passed comprehensive cannabis legalization bills. These bills are on their way to a conference committee to agree on the final wording – which must be approved again by both houses – before being sent…